Phenylketonuria cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
m (Categories) |
||
Line 2: | Line 2: | ||
{{Phenylketonuria}} | {{Phenylketonuria}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Line 7: | Line 8: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category: | [[Category:Endocrinology]] | ||
{{WS}} | |||
{{WH}} |
Latest revision as of 13:13, 26 July 2016
Phenylketonuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Phenylketonuria On the Web |
American Roentgen Ray Society Images of Phenylketonuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: